Celera Corp.’s (CRA) MACD indicator has crossed over to bearish territory with a reading of -0.0375. The Zacks #4 Rank (“Sell") stock has declined nearly 1% to $6.26 in afternoon trade. The full-year Zacks Consensus Estimate has reduced by 28 cents over the past month and is currently pegged at a loss of 27 cents per share."CRA" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research

For Immediate Release

Chicago, IL - May 12, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Curtiss-Wright Corp. (CW), Microchip Technology Inc. (MCHP), The Royal Bank of Scotland Group plc (RBS), Verisign Inc. (VRSN) and Celera Corp. (CRA).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Monday's Analyst Blog:

Curtiss-Wright Feels the Squeeze

Curtiss-Wright Corp. (CW) was caught in a classic economic squeeze during Q1-09: Sales were off a bit, while expenses generally went the other way; consequently, EPS were down a lot.

Net Sales were

...

For Immediate Release

Chicago, IL - April 27, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Lockheed Martin Corp (LMT), Schlumberger, Ltd. (SLB), Halliburton's (HAL), deCODE genetics, Inc. (DCGN) and Celera Corp. (CRA).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Friday's Analyst Blog:

Lockheed Beats & Ups Guidance

Lockheed Martin Corp (LMT) reported a 1st quarter 2009 profit of $666 million, down 9% from $730 million in the 1st quarter of 2008.

On a per-share basis, the reported result was $1.68 per diluted share, down 4% from $1.75 per diluted share

...

 Yesterday (Thursday), deCODE genetics, Inc. (DCGN) announced that the company signed an agreement with Celera Corp. (CRA). Pursuant to the agreement, deCODE granted Celera non-exclusive worldwide licenses to deCODE's genetic markers for increased risk of major cardiovascular and metabolic diseases, including heart attack, stroke, atrial fibrillation (AF) and type II diabetes. These markers can be incorporated into laboratory tests for assessing and managing individual risk of these diseases.The deCODE markers include single letter variations in the human genome (SNPs) on chromosome 9p21 linked to increased risk of heart attack and aortic aneurysm, SNPs on chromosome 4q25 conferring risk of AF and stroke, and SNPs in the TCF7L2 gene linked to increased risk of type II diabetes. Studies by deCODE and independent academic groups have demonstrated the utility of testing for these markers to better understand individual risk and to inform more effective and personalized prevention ...

The Zacks Rank Buys featured last week were: Questcor Pharmaceuticals, Inc. (...

Celera Corp. (...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Agree Realty Corp (ADC) Ajinomoto Co Inc (AJINY) Amerisafe Inc (AMSF) Bayer AG (BAYRY) Blackboard Inc (BBBB) Carriage Services Inc (CSV) Celera Corp (CRA) China Information Security Tech Inc (CPBY) DeVry Inc (DV) Dynamics Research Corp (DRCO) EF Johnson Technologies Inc (EFJI) Elbit Systems Ltd (ESLT) FiberTower Corp (FTWR) First California Financial Group Inc (FCAL) Flanders Corp (FLDR) Gmarket Inc (GMKT) Greatbatch Inc (GB) Kaman Corp (KAMN) LaCrosse Footwear Inc (BOOT) LJ International Inc (JADE) Magnetek Inc (MAG) Metabasis Therapeutics Inc (MBRX) Moog Inc (MOG.A) NCI Inc (NCIT) Novartis AG (NVS) Osteologix Inc (OLGX) Pegasystems Inc (PEGA) Power Medical Interventions Inc (PMII) Pressure BioSciences Inc (PBIO) ...